Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2001, p. 1367-1373, Vol. 45, No. 5
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1367-1373.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Anticandida Activity Is Retained in P-113, a
12-Amino-Acid Fragment of Histatin 5
David M.
Rothstein,1,*
Peter
Spacciapoli,1
Linh T.
Tran,1
Tao
Xu,2,
F. Donald
Roberts,1
Mauro
Dalla
Serra,3
Deborah K.
Buxton,1
Frank G.
Oppenheim,2 and
Phillip
Friden1
Periodontix, Inc., Watertown,
Massachusetts1; Department of
Periodontology and Oral Biology, Boston University, Boston,
Massachusetts2; and Centro di Fisica
Stati Aggregati, Trento, Italy3
Received 13 September 2000/Returned for modification 25 October
2000/Accepted 6 February 2001
Through the analysis of a series of 25 peptides composed of various
portions of the histatin 5 sequence, we have identified P-113, a
12-amino-acid fragment of histatin 5, as the smallest fragment that
retains anticandidal activity comparable to that of the parent
compound. Amidation of the P-113 C terminus increased the anticandidal
activity of P-113 approximately twofold. The three histidine residues
could be exchanged for three hydrophobic residues, with the fragment
retaining anticandidal activity. However, the change of two or more of
the five basic (lysine and arginine) residues to uncharged residues
resulted in a substantial loss of anticandidal activity. A synthetic
D-amino-acid analogue, P-113D, was as active against
Candida albicans as the L-amino-acid form. In
vitro MIC tests in low-ionic-strength medium showed that P-113 has
potent activity against Candida albicans, Candida glabrata, Candida parapsilosis, and Candida tropicalis. These
results identify P-113 as a potential antimicrobial agent in the
treatment of oral candidiasis.
*
Corresponding author. Mailing address: 107 Cedar St.,
Lexington, MA 02472. Phone: (781) 862-3801. Fax: (617) 926-4776. E-mail: drothstein{at}rcn.com.

Present address: Colgate-Palmolive Technical Center, Piscataway, NJ
08855.
Antimicrobial Agents and Chemotherapy, May 2001, p. 1367-1373, Vol. 45, No. 5
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1367-1373.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sun, X., Salih, E., Oppenheim, F. G., Helmerhorst, E. J.
(2009). Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal-binding, antifungal, and wound-healing properties. FASEB J.
23: 2691-2701
[Abstract]
[Full Text]
-
Chaffin, W. L.
(2008). Candida albicans Cell Wall Proteins. Microbiol. Mol. Biol. Rev.
72: 495-544
[Abstract]
[Full Text]
-
Jang, W. S., Li, X. S., Sun, J. N., Edgerton, M.
(2008). The P-113 Fragment of Histatin 5 Requires a Specific Peptide Sequence for Intracellular Translocation in Candida albicans, Which Is Independent of Cell Wall Binding. Antimicrob. Agents Chemother.
52: 497-504
[Abstract]
[Full Text]
-
Welling, M. M., Brouwer, C. P. J. M., van 't Hof, W., Veerman, E. C. I., Amerongen, A. V. N.
(2007). Histatin-Derived Monomeric and Dimeric Synthetic Peptides Show Strong Bactericidal Activity towards Multidrug-Resistant Staphylococcus aureus In Vivo. Antimicrob. Agents Chemother.
51: 3416-3419
[Abstract]
[Full Text]
-
Viejo-Diaz, M., Andres, M. T., Fierro, J. F.
(2005). Different Anti-Candida Activities of Two Human Lactoferrin-Derived Peptides, Lfpep and Kaliocin-1. Antimicrob. Agents Chemother.
49: 2583-2588
[Abstract]
[Full Text]
-
Wei, G.-X., Bobek, L. A.
(2005). Human Salivary Mucin MUC7 12-Mer-L and 12-Mer-D Peptides: Antifungal Activity in Saliva, Enhancement of Activity with Protease Inhibitor Cocktail or EDTA, and Cytotoxicity to Human Cells. Antimicrob. Agents Chemother.
49: 2336-2342
[Abstract]
[Full Text]
-
Santamaria, C., Larios, S., Quiros, S., Pizarro-Cerda, J., Gorvel, J.-P., Lomonte, B., Moreno, E.
(2005). Bactericidal and Antiendotoxic Properties of Short Cationic Peptides Derived from a Snake Venom Lys49 Phospholipase A2. Antimicrob. Agents Chemother.
49: 1340-1345
[Abstract]
[Full Text]
-
Giacometti, A., Cirioni, O., Kamysz, W., D'Amato, G., Silvestri, C., Prete, M. S. D., Licci, A., Riva, A., Lukasiak, J., Scalise, G.
(2005). In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised Patients. Antimicrob. Agents Chemother.
49: 1249-1252
[Abstract]
[Full Text]
-
Castagnola, M., Inzitari, R., Rossetti, D. V., Olmi, C., Cabras, T., Piras, V., Nicolussi, P., Sanna, M. T., Pellegrini, M., Giardina, B., Messana, I.
(2004). A Cascade of 24 Histatins (Histatin 3 Fragments) in Human Saliva: SUGGESTIONS FOR A PRE-SECRETORY SEQUENTIAL CLEAVAGE PATHWAY. J. Biol. Chem.
279: 41436-41443
[Abstract]
[Full Text]
-
Wei, G.-X., Bobek, L. A.
(2004). In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole. J Antimicrob Chemother
53: 750-758
[Abstract]
[Full Text]
-
Niemi, L. D., Johansson, I.
(2004). Salivary Statherin Peptide-Binding Epitopes of Commensal and Potentially Infectious Actinomyces spp. Delineated by a Hybrid Peptide Construct. Infect. Immun.
72: 782-787
[Abstract]
[Full Text]
-
Concannon, S. P., Crowe, T. D., Abercrombie, J. J., Molina, C. M., Hou, P., Sukumaran, D. K., Raj, P. A., Leung, K. -P.
(2003). Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol
52: 1083-1093
[Abstract]
[Full Text]
-
Fitzgerald, D. H., Coleman, D. C., O'Connell, B. C.
(2003). Susceptibility of Candida dubliniensis to Salivary Histatin 3. Antimicrob. Agents Chemother.
47: 70-76
[Abstract]
[Full Text]
-
Sajjan, U. S., Tran, L. T., Sole, N., Rovaldi, C., Akiyama, A., Friden, P. M., Forstner, J. F., Rothstein, D. M.
(2001). P-113D, an Antimicrobial Peptide Active against Pseudomonas aeruginosa, Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients. Antimicrob. Agents Chemother.
45: 3437-3444
[Abstract]
[Full Text]